Navigation Links
New Year's Resolution: Give Pets the Gift of Top-Notch Health Care
Date:1/14/2014

BURLINGAME, Calif., Jan. 14, 2014 /PRNewswire/ -- As pet owners drew up their lists of New Year's resolutions for 2014, there's no doubt many of them wrote: "Take better care of my furry companion." Nowadays there are pet salons, dog and cat therapists, and even designer clothes and top-brand carrying cases to take the little canine or feline darlings along wherever mommy or daddy goes. Pet parents might also feel compelled to buy some pricey toys at the pet store. But anyone who has ever lived with a dog or cat knows that most toys can't compete with that chewed-up baseball or shoe left lying around. Instead of spending the big bucks on Prada or Chanel couture for their cockapoo, pet owners should consider saving money for what really matters: the very best health care.

Keeping pets healthy starts with their owners. Feeding one's "baby" the correct food—and not letting it constantly munch on scraps from the dinner table—is step one. Many pet disorders originate from eating incompatible human foods. Step two is monitoring a pet's body and noting any changes. When a pet gets a belly rub, attention should be paid to any lumps, bumps or discolorations. A dog that limps when taken for a walk could be nothing serious—or the first sign of potentially serious medical issues. For human or beast alike, early detection is always a good way to find the ideal treatment.

One company is determined to help pet owners find those ideal treatments: Kindred Biosciences, Inc., a groundbreaking biopharmaceutical company headquartered in San Francisco. Kindred Bio is passionately dedicated to researching and developing the best medications for dogs, cats and horses.

"Our mission is simple," said Richard Chin, M.D., Kindred Bio's Founder and CEO. "We strive to bring the very best science and medicine to our animal companions." The company is currently developing a series of products including CereKin for osteoarthritis pain in dogs and horses; AtoKin for atopic dermatitis in dogs; and SentiKin for post-operative pain in dogs and horses. "We believe our research will relieve suffering and potentially save animals' lives," Chin adds.

For more information, visit www.kindredbio.com, who paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210


'/>"/>
SOURCE Kindred Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Steven F. Weiner, MD, of the Aesthetic Clinique in Santa Rosa Beach, Florida, Celebrates 20 Years of Botox Experience
2. BioTechniques Publishes Special Issue to Celebrate 30 Years of Life Science Methods and Techniques
3. JULABO USA Celebrates 20 Years in the U.S.A.
4. Colonoscopy screening every ten years could prevent 40% of colorectal cancers
5. Cato Research Celebrates 25 Years of Successful Life Science Research and Development
6. Celebrate Twenty Years of Good Business
7. India Bioinformatics Industry Market Size Expected to Grow by Average Annual Growth of 14.4% in the Next 5 Years: Ken Research
8. Bayer CropScience Celebrates 150 Years of Innovation; Asks for 150 Perspectives on the Future of Farming
9. French Man Surpasses Two Years of Support with SynCardia Total Artificial Heart
10. OrganJet customer receives kidney transplant years faster due to smart multiple listing
11. Food Safety Microbiology Testing Increases 40% in 5 Years to $2.9 Billion Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, Inc. ... and drug-delivery therapies, today announced that an Oncologic ... Drug Administration voted 11 to 0 that the ... injection was favorable for patients in the proposed ... and chronic lymphocytic leukemia. The FDA action date ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... it is exhibiting in booth 513 at the Association of Community Cancer Centers ... Hotel, March 29-31. , CANCERSCAPE unites key stakeholders from leading national organizations ...
(Date:3/29/2017)... and NEWARK, Del. , March ... privately-held regenerative medicine company, and W. L. Gore ... company, today announced a collaborative research agreement whereby the ... cell therapy delivery device technologies that provide protection from ... decade, ViaCyte has been developing innovative stem cell-derived cell ...
(Date:3/29/2017)... 29, 2017 Research and Markets has ... and Global Markets" report to their offering. ... The study ... sequencing, biochips, RNA interference, synthetic biology tools and genome editing ... These technologies and products are analyzed to determine ...
Breaking Biology Technology:
(Date:3/6/2017)... , March 6, 2017 ... sales technology, today announced Predictive Sales Coach TM ... infusing actionable sales intelligence into Salesforce. This unique ... enable their sales organizations with deep knowledge of ... allow for intelligent engagement. Predictive Sales Coach extends ...
(Date:3/2/2017)... 2017 Summary This report provides ... KGaA and its partnering interests and activities since 2010. ... Description The Partnering Deals and Alliance since 2010 report ... one of the world,s leading life sciences companies. ... to ensure inclusion of the most up to date ...
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
Breaking Biology News(10 mins):